Hexiu Su

630 total citations
11 papers, 383 citations indexed

About

Hexiu Su is a scholar working on Molecular Biology, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hexiu Su has authored 11 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hexiu Su's work include Acute Lymphoblastic Leukemia research (4 papers), Neuroblastoma Research and Treatments (4 papers) and RNA modifications and cancer (2 papers). Hexiu Su is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Neuroblastoma Research and Treatments (4 papers) and RNA modifications and cancer (2 papers). Hexiu Su collaborates with scholars based in China, United States and Belgium. Hexiu Su's co-authors include Hudan Liu, Guoliang Qing, Yufeng Hu, Daibiao Xiao, Ming Yue, Yue Ming, Jue Jiang, Hai‐Ning Du, Feng Li and Ping Ren and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hexiu Su

11 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hexiu Su China 8 281 124 107 64 58 11 383
Silvia Licciulli Italy 8 366 1.3× 83 0.7× 127 1.2× 59 0.9× 17 0.3× 8 470
Jessica Oddo United States 6 457 1.6× 87 0.7× 138 1.3× 30 0.5× 16 0.3× 10 558
Anqun Tang China 5 243 0.9× 50 0.4× 143 1.3× 137 2.1× 21 0.4× 6 361
Luana D’Artista Italy 7 414 1.5× 54 0.4× 228 2.1× 76 1.2× 22 0.4× 9 496
Jennifer C. Lam United States 6 217 0.8× 186 1.5× 60 0.6× 43 0.7× 11 0.2× 6 398
Zhen Ning Wee Singapore 4 267 1.0× 113 0.9× 111 1.0× 71 1.1× 13 0.2× 4 385
Ami Albihn Sweden 8 323 1.1× 83 0.7× 127 1.2× 38 0.6× 67 1.2× 8 426
Katya Nardou Switzerland 8 255 0.9× 83 0.7× 114 1.1× 33 0.5× 102 1.8× 10 366
Sara Rimpi Sweden 4 250 0.9× 93 0.8× 106 1.0× 85 1.3× 31 0.5× 4 331
Sandra Cantilena United Kingdom 9 202 0.7× 65 0.5× 87 0.8× 21 0.3× 111 1.9× 12 309

Countries citing papers authored by Hexiu Su

Since Specialization
Citations

This map shows the geographic impact of Hexiu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hexiu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hexiu Su more than expected).

Fields of papers citing papers by Hexiu Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hexiu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hexiu Su. The network helps show where Hexiu Su may publish in the future.

Co-authorship network of co-authors of Hexiu Su

This figure shows the co-authorship network connecting the top 25 collaborators of Hexiu Su. A scholar is included among the top collaborators of Hexiu Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hexiu Su. Hexiu Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Tianci, Jin Xu, Sanyun Wu, et al.. (2020). WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia. Haematologica. 106(7). 1816–1827. 23 indexed citations
2.
Jiang, Jue, Jingchao Wang, Ming Yue, et al.. (2020). Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis. Cancer Cell. 37(2). 200–215.e5. 79 indexed citations
3.
Song, Xiaoxue, Liyuan Wang, Tianci Wang, et al.. (2020). Synergistic targeting of CHK1 and mTOR in MYC-driven tumors. Carcinogenesis. 42(3). 448–460. 9 indexed citations
4.
Su, Hexiu, Liang Huang, Yang Yang, et al.. (2018). SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival. Nature Communications. 9(1). 4281–4281. 24 indexed citations
5.
Qin, You, Hexiu Su, Jingchao Wang, et al.. (2018). Animal models of T-cell acute lymphoblastic leukemia: mimicking the human disease. SHILAP Revista de lepidopterología. 1(1). 32–40. 1 indexed citations
6.
Tan, Xinle, Fei Gao, Hexiu Su, et al.. (2017). Genetic and Proteomic characterization of Bile Salt Export Pump (BSEP) in Snake Liver. Scientific Reports. 7(1). 43556–43556. 3 indexed citations
7.
Qi, Ye, Jue Jiang, Guanqun Zhan, et al.. (2016). Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia. Scientific Reports. 6(1). 26510–26510. 29 indexed citations
8.
Xiao, Daibiao, Yue Ming, Hexiu Su, et al.. (2016). Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival. Molecular Cell. 64(3). 493–506. 121 indexed citations
9.
Xiao, Daibiao, Ping Ren, Hexiu Su, et al.. (2015). Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2. Oncotarget. 6(38). 40655–40666. 67 indexed citations
10.
Hu, Yufeng, Hexiu Su, Xu Li, et al.. (2014). The NOTCH Ligand JAGGED2 Promotes Pancreatic Cancer Metastasis Independent of NOTCH Signaling Activation. Molecular Cancer Therapeutics. 14(1). 289–297. 26 indexed citations
11.
Liu, Hudan, Yufeng Hu, Hexiu Su, et al.. (2014). NOTCH1 Transcriptionally Activates Deptor and Promotes AKT Activation in Acute T-Cell Lymphoblastic Leukemia. Blood. 124(21). 895–895. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026